...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II.
【24h】

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II.

机译:咪唑并吡啶抗球虫剂的合成和生物活性:第二部分。

获取原文
获取原文并翻译 | 示例
           

摘要

Coccidiosis is the major cause of morbidity and mortality in the poultry industry. Protozoan parasites of the genus Eimeria invade the intestinal lining of the avian host causing tissue pathology, poor weight gain, and in some cases mortality. Resistance to current anticoccidials has prompted the search for new therapeutic agents with potent in vitro and in vivo activity against Eimeria. Recently, we reported the synthesis and biological activity of potent imidazo[1,2-a]pyridine anticoccidial agents. Antiparasitic activity is due to inhibition of a parasite specific cGMP-dependent protein kinase (PKG). In this study, we report the synthesis and anticoccidial activity of a second set of such compounds, focusing on derivatization of the amine side chain at the imidazopyridine 7-position. From this series, several compounds showed subnanomolar in vitro activity and commercial levels of in vivo activity. However, the potential genotoxicity of these compounds precludes them from further development.
机译:球虫病是家禽业发病率和死亡率的主要原因。艾美球虫属的原生动物寄生虫侵入禽类宿主的肠壁,引起组织病理学,体重增加不良,在某些情况下甚至导致死亡。对当前抗球虫药的耐药性促使人们寻找对艾美尔球虫具有强大的体外和体内活性的新治疗剂。最近,我们报道了强效咪唑并[1,2-a]吡啶抗球虫剂的合成和生物活性。抗寄生虫活性是由于抑制了寄生虫特异性cGMP依赖性蛋白激酶(PKG)。在这项研究中,我们报告了第二套这类化合物的合成和抗球虫活性,重点是在咪唑并吡啶7位胺侧链的衍生化。从该系列中,几种化合物显示出亚纳摩尔体外活性和商业水平的体内活性。但是,这些化合物的潜在遗传毒性使它们无法进一步开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号